Skip to main content Skip to section navigation Skip to footer
Aethlon Medical, Inc. Corporate Home
  • The Hemopurifier®
    • Overview
    • The Hemopurifier® in Cancer
    • The Hemopurifier® in Infectious Disease
  • About
    • Overview
    • Leadership
    • Board of Directors
  • News & Media
    • Press Releases
    • Presentations
    • Events
    • Publications
    • Training Videos
  • Investors
    • Overview
    • Corporate News / Events
    • Company Info
    • Financial Info
    • Stock Data
    • SEC Filings
    • Governance
    • Analyst Coverage
  • Contact Us
Site Announcement

Aethlon Medical is closely monitoring the Bird Flu situation and stands ready to work alongside hospitals, health agencies and the FDA if existing therapies prove inadequate.

News & Media
  • Press Releases
  • Presentations
  • Events
  • Publications
  • Training Videos

Press Releases

Aug 11, 2016

Aethlon Medical Announces Fiscal 2017 First Quarter Results

Aug 11, 2016

Aethlon Medical Announces Zika Virus Data

Aug 9, 2016

Aethlon Medical To Host First Quarter Fiscal 2017 Investor Call On August 11, 2016

Jun 29, 2016

Aethlon Medical Announces Fiscal 2016 Results

Jun 28, 2016

Aethlon Medical Announces $12.5 Million At The Market Program

Jun 27, 2016

Aethlon Medical Joins Russell Microcap® Index

Jun 27, 2016

Aethlon Medical to Host Fourth Quarter and Full Year Fiscal 2016 Investor Call On June 29, 2016

Jun 22, 2016

Aethlon Medical Set To Join Russell Microcap® Index

Jun 14, 2016

Aethlon Medical Announces Issuance Of Exosome Capture Patent

Jun 6, 2016

Aethlon Medical To Present Cancer And Infectious Disease Initiatives, As Well As Chronic Traumatic Encephalopathy (CTE) Candidate Biomarker Discovery At Tomorrow's BIO International Convention

  • Previous Pagearrow_back
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Next Pagearrow_forward
rss_feed News RSS
Linkedin
Privacy Policy Disclaimer Sitemap Accessibility Statement
©2025 Aethlon Medical, Inc. All Rights Reserved.